Concepedia

Annie Hilliard

AH

Statistics

Publications

3

Citations

286

H-Index

3

Active since

2011

Affiliations

GW Pharmaceuticals (United Kingdom)(Current)

Annie Hilliard is an author at GW Pharmaceuticals (United Kingdom) specializing in pharmacology, medicine, and psychopharmacology.

Publications per year

2011–2015

3

Publications

3

Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease

Maria Fleseriu, Rosario Pivonello, Jacques Young et al. · Pituitary · 2015 · 154 citations · Full text

Medicine, Endocrinology, Pharmacology +17

A randomized, double‐blind, placebo‐controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use

Kerri A. Schoedel, Nancy Chen, Annie Hilliard et al. · Human Psychopharmacology Clinical and Experimental · 2011 · 86 citations

Medicine, Pharmacology, Pharmacotherapy +17

Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis

Annie Hilliard, Colin Stott, Stephen Wright et al. · ISRN Neurology · 2012 · 46 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +15

1–3 of 3